Page last updated: 2024-12-05
phenoxarsine oxide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
phenoxarsine oxide: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 6017 |
SCHEMBL ID | 203388 |
MeSH ID | M0068542 |
Synonyms (54)
Synonym |
---|
c24h16as2o3 |
diphenoxarsin-10-yl oxide |
bis(10-phenoxarsinyl)oxide |
hsdb 6375 |
bis(10-phenoxyarsinyl) oxide |
vinyzene bp 5-2 |
obpa |
10,10'-oxybis-10h-phenoxarsine |
10-10' oxybisphenoxyarsine |
einecs 200-377-3 |
phenoxyarsine, 10,10'-oxybis- |
vinyzene bp 5 |
bis(10-phenoxarsyl) oxide |
did 47 |
vinadine |
phenoxarsine oxide |
phenoxaksine oxide |
vinyzene (pesticide) |
phenoxarsine, 10,10'-oxydi- |
10,10'-oxydiphenoxarsine |
10,10'-bis(phenoxyarsinyl) oxide |
10h-phenoxarsine, 10,10'-oxybis- |
durotex |
10,10'-oxidiphenoxarsine |
10,10'-oxybisphenoxy-arsine |
vinyzene sb 1 |
bis(phenoxarsin-10-yl) ether |
10,10'-oxybisphenoxarsine |
sa 546 |
brn 0055641 |
bis(10-phenoxarsyl)oxide |
10-phenoxarsinin-10-yloxyphenoxarsinine |
58-36-6 |
10,10-oxybisphenoxarsine |
2-27-00-00948 (beilstein handbook reference) |
1r0gee9l5z , |
vinyzene bs 1 |
unii-1r0gee9l5z |
10,10'-oxydiphenoxarsine [mi] |
bis(phenoxarsin-10-yl)ether |
vinyzene sb-1 |
10,10'-oxybis(phenoxarsine) |
AKOS022185378 |
SCHEMBL203388 |
10-(10h-phenoxarsin-10-yloxy)-10h-phenoxarsine # |
estabex abf |
bis(10-phenoxarsinyl) oxide |
DTXSID0032443 |
10,10'-oxybis(10h-phenoxarsinine) |
FT-0706583 |
Q3376217 |
H11760 |
A915131 |
CS-0161828 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.21
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.21) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |